Thursday, July 9, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ERNA”

213 pharma patents match "ERNA" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 213
Index total 30,257
Page 6 / 9

Quick answer

This filtered view shows 213 pharmaceutical patents matching "ERNA" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

213 results for “ERNA” · 30,257 patents in full index Clear search

  1. US 8865873

    Internalizing human monoclonal antibodies targeting prostate cancer cells in situ

    The Regents of the University of California · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  2. US 8865694

    Topical compositions for treatment of skin conditions

    Molecular Design International, Inc. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  3. US 8822218

    Method of generating natural killer cells and dendritic cells from human embryonic stem cell-derived hemangioblasts

    Stem Cell & Regenerative Medicine International · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  4. US 8816071

    Tocotrienol derivatives and associated methods

    First Tech International Limited · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  5. US 8815907

    Quaternary ammonium compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  6. US 8802856

    Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted

  7. US 8765680

    Method for administering omega-conopeptide

    Jazz Pharmaceuticals International III Limited · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted

  8. US 8709476

    Compositions of quaternary ammonium compounds containing bioavailability enhancers

    Supernus Pharmaceuticals, Inc. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  9. US 8703140

    Inhibition of factor B, the alternative complement pathway and methods related thereto

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  10. US 8653033

    Method for administering omega-conopeptide

    Jazz Pharmaceuticals International III Limited · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  11. US 8652475

    Inhibition of factor B, the alternative complement pathway and methods related thereto

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  12. US 8592453

    Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

  13. US 8563618

    Skin external preparation having excellent stability

    KURARAY CO., LTD. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  14. US 8513198

    Pharmaceutical formulation for reducing pain

    Jazz Pharmaceuticals International III Limited · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  15. US 8492407

    Quaternary ammonium compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  16. US 8426379

    POT1 alternative splicing variants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  17. US 8420620

    Induced internalization of surface receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted

  18. US 8378121

    Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted

  19. US 8329141

    Locoregional internal radionuclide ablation of abnormal tissues

    The Board of Regents of the University of Texas System · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

  20. US 8304439

    Use of quaternary pyridinium salts as a therapeutic or preventing agent against ionizing radiation-induced damage

    POLITECHNIKA LÓDZKA · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted

  21. US 8268786

    Anti-cancer tocotrienol analogues and associated methods

    First Tech International Limited · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

  22. US 8202891

    Quaternary ammonium compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted

  23. US 8183204

    Methods and compositions for increasing skin remodeling

    Summit Associates International Inc. · Granted May 22, 2012 · Expires May 17, 2032

    granted

  24. US 8173115

    Particle compositions with a pre-selected cell internalization mode

    The Board of Regents of the University of Texas System · Granted May 8, 2012 · Expires May 3, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.